More cutting-edge cancer research supported by industry
Nearly half of the research presented at ASCO's annual meeting last year came from researchers with ties to companies, and the amount appears to be increasing every year, according to new findings from Fox Chase Cancer Center. ...
Cancer
May 17, 2012 |
not rated yet |
0
Cancer vaccine combination therapy shows survival benefit in breast cancer
A vaccine that targets cancer cells in combination with the drug letrozole, a standard hormonal therapy against breast cancer, significantly increased survival when tested in mice, a team of UC Davis investigators has found.
Cancer
May 15, 2012 |
not rated yet |
0
Advances in personalized medicine for lung cancer
Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva.
Cancer
Apr 18, 2012 |
5 / 5 (1) |
0
Study examines adverse effects among different radiation therapies for prostate cancer
In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses ...
Cancer
Apr 17, 2012 |
4 / 5 (1) |
0
HIV raises anal cancer risk in women, study says
(HealthDay) -- Women with HIV are at increased risk for anal cancer, a new study finds.
HIV & AIDS
Apr 16, 2012 |
not rated yet |
0
Targeted therapeutics for colon cancer to be presented at AACR meeting
Anurag Singh, PhD, assistant professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine has been invited to present his recent work on targeted therapeutics for colon ...
Cancer
Apr 04, 2012 |
not rated yet |
0
Harmless human virus may be able to boost the effects of chemotherapy
A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer Research.
Cancer
Apr 03, 2012 |
5 / 5 (1) |
0
Pancreatic cancer clinical trial results released
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute ...
Cancer
Apr 03, 2012 |
not rated yet |
0
New study finds two-drug combo slows advanced pancreatic cancer
The combination of the novel drug TH-302 with the standard drug gemcitabine has shown early signs of delaying the worsening of cancer in patients with advanced pancreatic cancer, a Mayo Clinic-led study has found. This was ...
Cancer
Apr 03, 2012 |
not rated yet |
0
Early PET response to neoadjuvant chemo predicts increased survival in sarcoma patients
An early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas, according to a study by researchers ...
Cancer
Apr 02, 2012 |
not rated yet |
0
Two targeted therapies act against Ewing's sarcoma tumors
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
|
Oxygen in tumors predicts prostate cancer recurrence
Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy.
Cancer
Apr 01, 2012 |
5 / 5 (3) |
0
Genetic abnormality offers diagnostic hope for children's cancer
A chromosomal abnormality in children with a deadly form of brain cancer is linked with a poorer chance of survival, clinician scientists at The University of Nottingham have discovered.
Cancer
Mar 28, 2012 |
5 / 5 (1) |
0
|
Test for single genetic fault can help tailor cancer treatment for children
A study led by Dr Janet Shipley from The Institute of Cancer Research (ICR) in London in collaboration with Dr Mauro Delorenzi from the SIB Swiss Institute of Bioinformatics in Lausanne has shown that a simple genetic test ...
Cancer
Mar 27, 2012 |
not rated yet |
0
Scientists reprogram cancer cells with low doses of epigenetic drugs
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) ...
Cancer
Mar 22, 2012 |
5 / 5 (1) |
0
|
